Literature DB >> 17089178

Prescription of drugs blocking the renin-angiotensin system in Italian children.

Mario G Bianchetti1, Anita Ammenti, Luigi Avolio, Alberto Bettinelli, Maurizio Bosio, Emilio Fossali, Angela La Manna, Silvio Maringhini, Ivana Pela, Ilse M Ratsch, Sara Viganò, Gianluigi Ardissino.   

Abstract

Little is known about the prescription pattern of antihypertensive drugs for children with impaired kidney function. We have therefore documented the use of antihypertensive drugs in this patient group by evaluating the Italian pediatric population-based registry of patients with chronic kidney disease on conservative treatment (ItalKid) from 1995 to 2003. In 1995, prescriptions written for antihypertensive drugs for use by children were approximately equally divided among drugs blocking the renin-angiotensin system and calcium channel blockers (38 vs. 43% of all prescriptions), followed by beta-blockers and diuretics (15 and 4%, respectively). During subsequent years the proportion of prescriptions for drugs blocking the renin-angiotensin system increased (2003: 61%; p<0.001) and that of calcium channel blockers decreased (2003: 18%, p<0.001). In 1995, blockers of the renin-angiotensin system were prescribed, either as monotherapy or in combination, in 53% of the patients, but the relative frequency of the patients prescribed these drugs increased up to 83% in 2003 (p<0.0005). In conclusion, physicians caring for Italian children with impaired kidney function are increasingly prescribing drugs blocking the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17089178     DOI: 10.1007/s00467-006-0293-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  13 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  Tips for the use of antihypertensive drugs: DELTAREPROSI.

Authors:  Mario G Bianchetti; Gianluigi Ardissino; Emilio Fossali; Gian Paolo Ramelli; Patrizia Salice
Journal:  J Pediatr       Date:  2004-09       Impact factor: 4.406

3.  Hypertension in dialysed children: the prevalence and therapeutic approach in Poland--a nationwide survey.

Authors:  Marcin Tkaczyk; Michał Nowicki; Irena Bałasz-Chmielewska; Hanna Boguszewska-Baçzkowska; Dorota Drozdz; Barbara Kołłataj; Tomasz Jarmoliński; Katarzyna Jobs; Katarzyna Kiliś-Pstrusińska; Beata Leszczyńska; Irena Makulska; Dariusz Runowski; Roman Stankiewicz; Maria Szczepańska; Ryszard Wierciński; Ryszard Grenda; Andrzej Kanik; Jacek A Pietrzyk; Maria Roszkowska-Blaim; Krystyna Szprynger; Jacek Zachwieja; Maria M Zajaczkowska; Walentyna Zoch-Zwierz; Danuta Zwolińska; Aleksandra Zurowska
Journal:  Nephrol Dial Transplant       Date:  2005-11-22       Impact factor: 5.992

4.  Epidemiology of chronic renal failure in children: data from the ItalKid project.

Authors:  Gianluigi Ardissino; Valeria Daccò; Sara Testa; Roberto Bonaudo; Aldo Claris-Appiani; Emanuela Taioli; Giuseppina Marra; Alberto Edefonti; Fabio Sereni
Journal:  Pediatrics       Date:  2003-04       Impact factor: 7.124

5.  How are hypertensive children evaluated and managed? A survey of North American pediatric nephrologists.

Authors:  Robert P Woroniecki; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2005-04-05       Impact factor: 3.714

6.  Academic detailing to improve antihypertensive prescribing patterns.

Authors:  David Siegel; Julio Lopez; Joy Meier; Mary K Goldstein; Samuel Lee; Bradley J Brazill; Mazen S Matalka
Journal:  Am J Hypertens       Date:  2003-06       Impact factor: 2.689

7.  Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.

Authors:  Demetrius Ellis; Michael L Moritz; Abhay Vats; Janine E Janosky
Journal:  Am J Hypertens       Date:  2004-10       Impact factor: 2.689

8.  Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure.

Authors:  Elke Wühl; Otto Mehls; Franz Schaefer
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

Review 9.  Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both?

Authors:  Karl F Hilgers; Jörg Dötsch; Wolfgang Rascher; Johannes F E Mann
Journal:  Pediatr Nephrol       Date:  2004-07-22       Impact factor: 3.714

10.  Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood.

Authors:  Anne C Gartenmann; Emilio Fossali; Rodo O von Vigier; Giacomo D Simonetti; Jan Schmidtko; Alberto Edefonti; Mario G Bianchetti
Journal:  Kidney Int       Date:  2003-10       Impact factor: 10.612

View more
  2 in total

Review 1.  Systemic hypertension and proteinuria in childhood chronic renal parenchymal disease: role of antihypertensive drug management.

Authors:  Giacomo D Simonetti; Laura Santoro; Alessandra Ferrarini; Laura Crosazzo-Franscini; Emilio Fossali; Mario G Bianchetti
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 2.  Hypertension in children with chronic kidney disease: pathophysiology and management.

Authors:  Charlotte Hadtstein; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2007-11-08       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.